JP2024169482A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024169482A5 JP2024169482A5 JP2024158947A JP2024158947A JP2024169482A5 JP 2024169482 A5 JP2024169482 A5 JP 2024169482A5 JP 2024158947 A JP2024158947 A JP 2024158947A JP 2024158947 A JP2024158947 A JP 2024158947A JP 2024169482 A5 JP2024169482 A5 JP 2024169482A5
- Authority
- JP
- Japan
- Prior art keywords
- silicon
- composition
- phosphatidylcholine
- composition according
- glycine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1904337.1 | 2019-03-28 | ||
| GBGB1904337.1A GB201904337D0 (en) | 2019-03-28 | 2019-03-28 | A delivery system |
| PCT/GB2020/050854 WO2020193999A1 (en) | 2019-03-28 | 2020-03-30 | A delivery system comprising silicon nanoparticles |
| JP2021557827A JP7637416B2 (ja) | 2019-03-28 | 2020-03-30 | ケイ素ナノ粒子を含む送達システム |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557827A Division JP7637416B2 (ja) | 2019-03-28 | 2020-03-30 | ケイ素ナノ粒子を含む送達システム |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024169482A JP2024169482A (ja) | 2024-12-05 |
| JP2024169482A5 true JP2024169482A5 (https=) | 2025-04-10 |
| JP7784754B2 JP7784754B2 (ja) | 2025-12-12 |
Family
ID=66442849
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557827A Active JP7637416B2 (ja) | 2019-03-28 | 2020-03-30 | ケイ素ナノ粒子を含む送達システム |
| JP2024158947A Active JP7784754B2 (ja) | 2019-03-28 | 2024-09-13 | ケイ素ナノ粒子を含む送達システム |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021557827A Active JP7637416B2 (ja) | 2019-03-28 | 2020-03-30 | ケイ素ナノ粒子を含む送達システム |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12496278B2 (https=) |
| EP (1) | EP3946280A1 (https=) |
| JP (2) | JP7637416B2 (https=) |
| CN (2) | CN117398362A (https=) |
| AU (1) | AU2020249810B2 (https=) |
| CA (1) | CA3133117C (https=) |
| GB (1) | GB201904337D0 (https=) |
| WO (1) | WO2020193999A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022132196A (ja) * | 2021-02-26 | 2022-09-07 | ナノ ターゲティング アンド セラピー バイオファーマ インコーポレイテッド | 薬剤を後眼部に送達するための方法およびその使用 |
| GB202110645D0 (en) * | 2021-07-23 | 2021-09-08 | Sisaf Ltd | Protection of biological molecules from degradation |
| GB202110644D0 (en) * | 2021-07-23 | 2021-09-08 | Sisaf Ltd | Improved nucleic acid vector particles |
| GB202110646D0 (en) * | 2021-07-23 | 2021-09-08 | Sisaf Ltd | Nucleic acid vector compositions |
| CN121622565A (zh) * | 2022-05-16 | 2026-03-10 | 苏州维益生物科技有限公司 | 纳米颗粒、其制备和应用、及包括其的眼疾药物及其制备 |
| GB202210794D0 (en) | 2022-07-22 | 2022-09-07 | Sisaf Ltd | Lipid formulations |
| GB202300914D0 (en) * | 2023-01-20 | 2023-03-08 | Sisaf Ltd | Manufacturing process |
| GB202300915D0 (en) * | 2023-01-20 | 2023-03-08 | Sisaf Ltd | mRNA COMPOSITIONS |
| GB202300911D0 (en) * | 2023-01-20 | 2023-03-08 | Sisaf Ltd | Therapeutic compositions and methods |
| GB202300912D0 (en) * | 2023-01-20 | 2023-03-08 | Sisaf Ltd | Therapeutic compostions and methods |
| CN116473928B (zh) * | 2023-03-01 | 2024-06-14 | 东北师范大学 | 精氨酸/磷酸钙纳米粒子的制备方法及其应用 |
Family Cites Families (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK175531B1 (da) | 1986-12-15 | 2004-11-22 | Nexstar Pharmaceuticals Inc | Leveringsvehikel med amphiphil-associeret aktiv bestanddel |
| NL9400189A (nl) | 1994-02-07 | 1995-09-01 | Bio Pharma Sciences Bv | Gestabiliseerd orthosiliciumzuur bevattend preparaat, een werkwijze voor het bereiden daarvan en een biologisch preparaat. |
| CN1227482A (zh) | 1996-06-27 | 1999-09-01 | 普罗克特和甘保尔公司 | 化妆品组合物 |
| FR2799758B1 (fr) | 1999-10-15 | 2002-05-17 | Exsymol Sa | Complexe a base d'acide orthosilicique biologiquement assimilable, se presentant sous forme solide, stable et concentree, et procede de preparation |
| GB0104383D0 (en) | 2001-02-22 | 2001-04-11 | Psimedica Ltd | Cancer Treatment |
| US6670335B2 (en) | 2001-03-05 | 2003-12-30 | A. P. Pharma, Inc. | Fluorouracil-containing formulation |
| EP1391426A1 (en) | 2002-08-12 | 2004-02-25 | Bio Minerals N.V. | Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| JP2006016390A (ja) | 2004-06-04 | 2006-01-19 | Toyo Shinyaku:Kk | プロアントシアニジン含有組成物 |
| CN1981044B (zh) * | 2004-06-07 | 2010-05-05 | 普洛体维生物治疗公司 | 包封干扰rna的脂质 |
| ES2669585T3 (es) | 2004-10-29 | 2018-05-28 | The Regents Of The University Of California | Micropartículas porosas de silicio para la entrega de fármaco para el ojo |
| CN101277704A (zh) * | 2005-04-12 | 2008-10-01 | 因特拉迪格姆公司 | 用于治疗癌症及其它新血管生成疾病的RNAi治疗剂的组合物和方法 |
| GB0515353D0 (en) | 2005-07-27 | 2005-08-31 | Psimedica Ltd | Food |
| US8920821B2 (en) | 2006-04-14 | 2014-12-30 | Perrigo Israel Pharmaceuticals Ltd. | Pharmaceutical compositions comprising silica microspheres |
| US7696866B2 (en) | 2007-06-28 | 2010-04-13 | Microsoft Corporation | Learning and reasoning about the context-sensitive reliability of sensors |
| KR20160021307A (ko) * | 2007-07-10 | 2016-02-24 | 더 리전트 오브 더 유니버시티 오브 캘리포니아 | 선택된 조직에 조성물을 전달하는 물질 및 방법 |
| US20090053268A1 (en) | 2007-08-22 | 2009-02-26 | Depablo Juan J | Nanoparticle modified lubricants and waxes with enhanced properties |
| EP2030632A1 (en) | 2007-09-03 | 2009-03-04 | UMC Utrecht Holding B.V. | A carrier particle for use in bio-applications |
| GB0817936D0 (en) | 2008-09-30 | 2008-11-05 | Intrinsiq Materials Global Ltd | Porous materials |
| IT1394656B1 (it) | 2009-07-03 | 2012-07-05 | Brev Angela Srl | Processo per la produzione e l'assemblaggio di una siringa per operazioni medicali |
| GB0913255D0 (en) | 2009-07-30 | 2009-09-02 | Sisaf Ltd | Topical composition |
| JP2011032194A (ja) | 2009-07-31 | 2011-02-17 | Kracie Home Products Ltd | 油中水型乳化化粧料 |
| US8992984B1 (en) | 2009-10-21 | 2015-03-31 | Stc.Unm | Protocells and their use for targeted delivery of multicomponent cargos to cancer cells |
| ES2385080B1 (es) * | 2010-12-21 | 2013-05-10 | Universidad Del Pais Vasco-Euskal Herriko Unibertsitatea | Nanopartículas lipídicas para el tratamiento de enfermedades oculares. |
| EP2765997A4 (en) | 2011-10-14 | 2015-06-24 | Stc Unm | POROUS NANOPARTICLE-SUPPORTED LIPID DOUBLE LAYERS (PROTOCOLS) FOR THE TARGETED RELEASE BY TRANSDERMAL RELEASE AND USE METHOD THEREFOR |
| US9096679B2 (en) * | 2012-12-03 | 2015-08-04 | The Board Of Regents Of The University Of Oklahoma | Peptide compounds and methods of production and use thereof |
| EP2968571A4 (en) | 2013-03-15 | 2016-09-07 | Psivida Inc | BIODEGRADABLE SILICONE BASED COMPOSITIONS FOR THE DELIVERY OF THERAPEUTIC AGENTS |
| US20170165375A1 (en) | 2013-04-02 | 2017-06-15 | Stc. Unm | Antibiotic protocells and related pharmaceutical formulations and methods of treatment |
| JP2016521568A (ja) | 2013-06-12 | 2016-07-25 | ユニヴェルシテ・ドゥ・ナミュールＵｎｉｖｅｒｓｉｔｅ ｄｅ Ｎａｍｕｒ | 生細胞の冷凍保存 |
| EP3470089A1 (en) * | 2013-12-12 | 2019-04-17 | The Broad Institute Inc. | Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components |
| GB201402669D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Stabilised silicate compositions and their uses |
| EP2946793A1 (en) * | 2014-05-23 | 2015-11-25 | Universitat Rovira I Virgili | Silicon particles targeting tumor cells |
| CN104127886A (zh) | 2014-07-16 | 2014-11-05 | 上海理工大学 | 一种CpG核酸药物输送系统及其制备方法 |
| CN105434205A (zh) | 2014-11-08 | 2016-03-30 | 马南行 | 一种眼部快速弹开皱纹延缓衰老的组合物及其制备方法 |
| CN114533898B (zh) * | 2015-07-09 | 2025-07-01 | 加利福尼亚大学董事会 | 融合脂质体包被的多孔硅纳米颗粒 |
| LU92784B1 (en) | 2015-07-22 | 2017-01-31 | Luxembourg Inst Of Science And Tech (List) | Negatively charged self-assembling supported lipid bilayer on mesoporous silica nanoparticles, method of synthesis and use as a nanovector |
| WO2017040976A1 (en) * | 2015-09-02 | 2017-03-09 | Erkki Ruoslahti | Compounds and compositions for targeting brain injuries and methods of use thereof |
| US20180344641A1 (en) | 2015-09-04 | 2018-12-06 | C. Jeffrey Brinker | Mesoporous silica nanoparticles and supported lipid bi-layer nanoparticles for biomedical applications |
| US20190262469A1 (en) | 2015-09-04 | 2019-08-29 | C. Jeffrey Brinker | Protocells to treat microbial infection and for synergistic delivery |
| JP7384512B2 (ja) * | 2015-10-22 | 2023-11-21 | モデルナティエックス インコーポレイテッド | 広域インフルエンザウイルスワクチン |
| EP4218739A3 (en) | 2016-01-08 | 2023-08-09 | The Regents of The University of California | Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery |
| WO2017181115A1 (en) * | 2016-04-14 | 2017-10-19 | Spinnaker Biosciences, Inc. | Porous silicon materials comprising a metal silicate for delivery of therapeutic agents |
| CN106177982A (zh) | 2016-07-26 | 2016-12-07 | 上海应用技术学院 | 一种透明质酸修饰的脂质介孔硅核壳纳米组装体及其制备方法 |
| JP7510254B2 (ja) | 2016-08-10 | 2024-07-03 | ユナイテッド キングダム リサーチ アンド イノベーション | ナノシリカ粒子を含む組成物および療法のためにｔリンパ球を活性化する方法におけるそれらの使用 |
| CN106265432A (zh) | 2016-08-30 | 2017-01-04 | 钟治超 | 一种含有薄荷精油的美白美容乳剂 |
| LU100023B1 (en) | 2017-01-20 | 2018-07-30 | Luxembourg Inst Science & Tech List | Nanocapsules and method for manufacturing thereof |
| CN106806343B (zh) | 2017-02-17 | 2020-10-13 | 清华大学深圳研究生院 | 一种叶酸和聚多巴胺修饰的肿瘤靶向介孔二氧化硅纳米粒及制备方法与应用 |
| US20200261580A1 (en) | 2017-07-17 | 2020-08-20 | Andrea Willey | Photodynamic Therapy Method for Skin Disorders |
| US20200375912A1 (en) | 2017-08-03 | 2020-12-03 | Rita Elena Serda | Liposomal coated nanoparticles for immunotherapy applications |
| CN107625966A (zh) | 2017-09-10 | 2018-01-26 | 河南工业大学 | 一种自组装式脂质‑介孔硅核/壳复合型纳米药物载体及其制备方法 |
| CN107616952A (zh) | 2017-10-31 | 2018-01-23 | 广州赛莱拉干细胞科技股份有限公司 | 一种含菊花细胞提取物的祛皱护肤组合物及其制备方法 |
| CN107998264A (zh) | 2018-01-15 | 2018-05-08 | 福建傲农生物科技集团股份有限公司 | 一种治疗猪呼吸道疾病的中西药复方超微粉剂及其制备方法与应用 |
| CN108552223A (zh) | 2018-01-17 | 2018-09-21 | 天津市植物保护研究所 | 一种含芽胞杆菌的液体菌悬剂及其应用 |
-
2019
- 2019-03-28 GB GBGB1904337.1A patent/GB201904337D0/en not_active Ceased
-
2020
- 2020-03-30 CA CA3133117A patent/CA3133117C/en active Active
- 2020-03-30 EP EP20718725.3A patent/EP3946280A1/en active Pending
- 2020-03-30 US US17/598,703 patent/US12496278B2/en active Active
- 2020-03-30 WO PCT/GB2020/050854 patent/WO2020193999A1/en not_active Ceased
- 2020-03-30 CN CN202311342050.3A patent/CN117398362A/zh active Pending
- 2020-03-30 AU AU2020249810A patent/AU2020249810B2/en active Active
- 2020-03-30 CN CN202080025724.5A patent/CN113677332B/zh active Active
- 2020-03-30 JP JP2021557827A patent/JP7637416B2/ja active Active
-
2024
- 2024-09-13 JP JP2024158947A patent/JP7784754B2/ja active Active
-
2025
- 2025-11-06 US US19/381,591 patent/US20260096997A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024169482A5 (https=) | ||
| JP2022529579A5 (https=) | ||
| Li et al. | Nanotechnology-based ocular drug delivery systems: recent advances and future prospects | |
| Tawfik et al. | Nanomedicine and drug delivery to the retina: current status and implications for gene therapy | |
| F Fangueiro et al. | Ocular drug delivery-new strategies for targeting anterior and posterior segments of the eye | |
| Bairagi et al. | Ocular drug delivery systems based on nanotechnology: a comprehensive review for the treatment of eye diseases | |
| JP7026507B2 (ja) | 眼において薬物徐放を達成する方法及び生体適合性組成物 | |
| Chennamaneni et al. | Development of a novel bioerodible dexamethasone implant for uveitis and postoperative cataract inflammation | |
| Puglia et al. | Lipid nanocarriers (LNC) and their applications in ocular drug delivery | |
| Raj et al. | Ocular drug delivery system: challenges and approaches | |
| US20170157038A1 (en) | Ophthalmic drug delivery method | |
| Amrutkar et al. | Nanocarriers for ocular drug delivery: recent advances and future opportunities | |
| Shivhare et al. | An update review on novel advanced ocular drug delivery system | |
| JP2024534570A5 (https=) | ||
| Zhang et al. | Intractable ocular diseases and treatment progress | |
| Kesavan et al. | Topical ocular delivery of nanocarriers: A feasible choice for glaucoma management | |
| Vishal et al. | Current status and advanced approaches in ocular drug delivery system | |
| Pignatello et al. | Nanotechnology in ophthalmic drug delivery: a survey of recent developments and patenting activity | |
| Amrite et al. | Nanoparticles for ocular drug delivery | |
| Hajare et al. | A rational approach to ocular drug delivery systems: A overview | |
| Tang et al. | Applications and latest research progress of liposomes in the treatment of ocular diseases | |
| Jani et al. | Ocular Drug Delivery Systems | |
| Rawat et al. | Nanotechnology advancements in treating ocular infectious diseases: a paradigm shift in therapeutic strategies | |
| Bennett | Topical versus systemic ocular drug delivery | |
| Herrero-Vanrell et al. | Ocular pharmacokinetic drug, bioavailability and intraocular drug delivery systems |